Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults
Clinical trial NCT07176208 · RECRUITING
Trial details
- NCT number
- NCT07176208
- Sponsor
- Food and Drug Administration (FDA)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-29
- Primary completion
- 2026-04-14
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.